Alerus Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Alerus Investment Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$7.28M	Buy	83,763 +4,617	+6%	+$413K	1.27%	17
2015 Q4	$8.93M	Buy	79,146 +753	+1%	+$81.7K	1.49%	14
2015 Q3	$7.93M	Sell	78,393 -21,636	-22%	-$2.6M	1.4%	15
2015 Q2	$11.5M	Sell	100,029 -75	-0.1%	-$8.98K	1.9%	8
2015 Q1	$11.4M	Sell	100,104 -4,815	-5%	-$531K	1.9%	8
2014 Q4	$10.6M	Buy	104,919 +17,346	+20%	+$1.69M	1.8%	8
2014 Q3	$7.99M	Sell	87,573 -5,997	-6%	-$526K	1.38%	10
2014 Q2	$8.02M	Buy	93,570 +22,449	+32%	+$1.77M	1.38%	11
2014 Q1	$5.6M	Sell	71,121 -9,015	-11%	-$751K	1.21%	17
2013 Q4	$6.07M	Sell	80,136 -28,914	-27%	-$2.05M	1.34%	20
2013 Q3	$7.62M	Sell	109,050 -5,394	-5%	-$353K	1.52%	11
2013 Q2	$6.63M	Buy	+114,444	New	+$6.62M	1.02%	31

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Alerus Investment Advisors's IBB Position: Q1 2016 in Review

Alerus Investment Advisors increased its iShares Biotechnology ETF (IBB) stake by 5.8% in Q1 2016, buying an estimated $413K and bringing the position to 83,763 shares worth $7.28M. The position accounts for 1.27% of the portfolio, ranked #17.

Alerus Investment Advisors first reported a position in IBB in Q2 2013 and has held it in 12 quarters since. The position peaked at $11.5M in Q2 2015. 415 funds tracked by Wall St. Rank hold IBB as of Q1 2016.

Alerus Investment Advisors held 83,763 shares of iShares Biotechnology ETF worth $7.28M as of Q1 2016.
Alerus Investment Advisors bought 4,617 iShares Biotechnology ETF shares in Q1 2016, an estimated $413K.
iShares Biotechnology ETF made up 1.27% of Alerus Investment Advisors's portfolio in Q1 2016, its #17 holding.
Alerus Investment Advisors first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 12 quarters since.
Alerus Investment Advisors's iShares Biotechnology ETF position peaked at $11.5M in Q2 2015.
415 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2016.

Based on Alerus Investment Advisors's 13F filing for Q1 2016, filed 4 May 2016.